The balloon valvuloplasty devices market size was valued at USD 2.40 billion in 2024 and is expected to reach USD 3.66 billion by 2032, growing at a CAGR of 5.44% over the forecast period of 2025-2032.
The global balloon valvuloplasty devices market is projected to observe steady growth owing to the increasing number of valvular heart diseases, such as aortic and pulmonary stenosis, among the aging population. Decline of open heart surgeries and increasing applications of pediatric surgeries are also driving the growth of the market. Other factors contributing to the growth of the market are technological advancements in balloon design and increased use in ambulatory settings. Emerging economies with favorable reimbursement policies will help the market to continue to grow through 2032.
The U.S. balloon valvuloplasty devices market size was valued at USD 0.84 billion in 2024 and is expected to reach USD 1.25 billion by 2032, growing at a CAGR of 5.12% over the forecast period of 2025-2032.
In North America, the U.S. is anticipated to be a significant contributor balloon valvuloplasty devices market growth, owing to its advanced healthcare infrastructure, early adoption of minimally invasive cardiac procedures, and a high prevalence of valvular heart diseases. Coupled with robust clinical research infrastructure, a large number of interventional cardiologists, and favorable reimbursement policies, the country remains a leader within the region.
Drivers
Increased Incidence of Heart Disorders Related to Valves is Driving the Market Growth
Valvular heart diseases, especially aortic and pulmonary valve stenosis, are becoming more prevalent globally, particularly in the elderly population. For instance, calcific aortic stenosis is one of the most frequently diagnosed valve diseases in the elderly and is generally due to age-related calcification of the valve. The global burden of these diseases continues to increase due to aging populations, emerging lifestyle-related risk factors (especially hypertension and diabetes), and advancements in diagnostic technology. Balloon valvuloplasty is a less invasive procedure that is suitable for patients who are not best suited for open-heart surgery. It is the procedure of choice in the high-risk and elderly patient population. With the increasing number of cases being diagnosed, the need for an effective treatment modality, such as balloon valvuloplasty is on the rise.
Advancements in Device Technology are Propelling the Market Growth
Major advancements in technology have made balloon valvuloplasty a safer, more precise, and more successful procedure. Currently available new-generation balloons, including high-pressure balloons and scoring balloons, provide greater control in handling on dilation with effective treatment even in heavily calcified or fibrotic valves. They are designed to provide more localized and controlled expansion, hence causing less injury to adjacent tissues and lower rates of complications such as restenosis or valve rupture. Furthermore, enhanced delivery systems for the catheter, and image integration, have made the procedure more accurate and attracted interventional cardiologists to the larger utilization of this approach. Advance in technology makes the treatment more effective and also broaden the scope of patients suitable for balloon valvuloplasty.
Restraints:
Short-Term Efficacy and Risk of Restenosis are Restraining the Market from Growing
The main disadvantage of balloon valvuloplasty is its transient effect, particularly in adults with aortic valve stenosis. Although this technique effectively widens a stenosed valve and allows blood to flow more freely in the short term, the valve often then becomes stenosed again after some time, a process called restenosis. In the majority of adult cases, this recurrence can occur within 6 to 12 months after the procedure, necessitating repeat interventions or valve replacements.
In older patients, valve structures are calcified and fibrotic, resulting in less responsive tissue to balloon dilation and hence an increased risk of restenosis. Consequently, balloon valvuloplasty is more of a palliative or bridging treatment rather than a definitive treatment. This short durability is less desirable than more durable therapies such as TAVR or surgical valve replacement, especially in patients who are well enough to consider them.
By Product Type
The high-pressure balloon segment accounted for the largest market share in 2024, with a 45.80% market share. These are much more powerful balloons with higher burst pressure and are useful for opening heavily stenosed valves, especially in elderly patients with calcific aortic stenosis. The ability to be used independently or as preparation for transcatheter valve replacements has further added to their adoption in hospitals and cardiac centers, making them the leading market share holder.
The scoring balloon segment is expected to register the fastest growth during the forecast period. The demand for precision with controlled plaque modification in complex valvular cases drives this growth. These scoring balloons contain special components that exert a concentrated force, producing a more efficient dilation with minimal vessel injury. Scoring balloons are gaining popularity among interventional cardiologists as these devices achieve both an improved safety and procedural success profile with the continuing evolution of minimally invasive skills, which are needed particularly in complex and high-risk patient populations.
By Application
In 2024, the aortic valve stenosis segment led the balloon valvuloplasty devices market share with 66.2%, owing to the high population with this condition among the geriatric population. Aortic stenosis is among the commonest and most serious of valvular heart diseases and is one of the most frequent indications for intervention in the older population. Balloon aortic valvuloplasty (BAV) is often employed as a bridge-to-surgery or TAVR in high-risk surgical patients. The high share of the segment is mainly driven by the increasing prevalence of degenerative valve diseases and the high availability of interventional cardiology services in developed regions.
The pulmonary valve stenosis segment is expected to grow at the fastest rate in the forecast period on account of the growing number of congenital heart defects in neonates and pediatrics. Balloon pulmonary valvuloplasty is a standard treatment for these patients and has recorded good outcomes in pediatric cohorts over the long term. A rise in the need for pediatric cardiology is propelled by increased utilization of technology, awareness, and increasing access to advanced care in developing markets. In addition, the advancements in neonatal screening along with early intervention strategies are increasing the treatment rates and this segment is projected to grow at a healthy pace.
By Age Group
In 2024, the adult segment dominated the balloon valvuloplasty devices market with an 84.25% market share, due to the rapidly growing degenerative valvular diseases seen in the elderly population, especially aortic valve stenosis. Calcific valve disease is primarily found in adults, more often than not in older patients aged over 65 years, and typically treated least invasively (balloon valvuloplasty), as a treatment or at least as a bridge to operative valve replacement. This segment's dominance can be attributed, in part, to improved availability of diagnostic tools, interventional facilities, and established reimbursement frameworks in developed regions.
The fastest growth is anticipated in the Pediatric segment. This growth is mainly driven by a greater awareness and increased identification of congenital heart defects, including a stenosis of the pulmonary valve, that are more common in children. Minimally invasive and with excellent long-term results, balloon valvuloplasty is often the first indication that the condition exists in pediatric cases. Moreover, investing in introducing more pediatric cardiac care, advancement in neonatal screening programs, and adaptation toward pediatric cardiology services in developing economies will also drive this segment most rapidly.
By End-Use
In 2024, the Hospitals segment dominated the balloon valvuloplasty devices market with a 63.11% market share due to the infrastructure and expertise to address and treat high-risk and complicated valvular procedures. The deployment of comprehensive cardiac healthcare practices facilitates the repair of multiple valvular regions while minimizing hospital stay times through the use of balloon valvuloplasty devices. Hospitals tend to be the main location for complex cardiovascular interventions such as balloon valvuloplasty, especially with acute or emergent care.
The Ambulatory Surgical Centres (ASCs) segment is expected to witness the fastest growth during the forecast period as the cost-effective nature and value of same-day cardiac procedures drive demand. With the development of newer balloon catheter technologies and enhanced patient safety practices, it has become feasible for select valvuloplasty cases to be performed in an outpatient setting. Analysis notes that the ASC model provides shorter procedures, shorter hospital stays, and therefore lower cost of care, all of which may contribute to its growing preference among its patient and provider base. The trend toward value-based care and less invasive procedures remains a tailwind, and it continues to bolster ASC growth across developed and emerging markets.
The balloon valvuloplasty devices market is dominated by North America with a 40.4% market share in 2024 due to having an ideal healthcare infrastructure, a large population, good awareness regarding structural heart diseases, advanced cardiac intervention technology, early adoption for diagnostics and treatment, and evolving reimbursement policies. Despite the limitations in the procedure, balloon valvuloplasty is performed globally, and constant clinical research activity and leading MD companies are present in India, which together explain the overuse of this procedure, especially in aortic valve stenosis.
The fastest growing region in the balloon valvuloplasty devices market is in Asia Pacific with a 6.00% CAGR over the forecast period due to the increasing accessibility to health care services, increasing incidence of rheumatic and congenital cardiovascular diseases, along with an aging population. Growth of the market include rapid development of healthcare infrastructure, rising investments by international and domestic device manufacturing companies, and increasing awareness toward the advanced treatment methods, including minimally invasive techniques, which are primarily boosting the growth of the market. In addition, the increasing medical tourism in countries, such as India, China, and Thailand, along with favorable government initiatives, is contributing to the growth of the region.
The balloon valvuloplasty devices market in the European region is growing at a significant rate due to the increases in the healthcare infrastructure and the number of interventional cardiology procedures. The presence of a large geriatric population is resulting in a higher prevalence of valvular heart diseases in the region, which, in turn, will continue to spur the demand for balloon valvuloplasty, as it is preferred in hospitals for minimally invasive treatment of VHD. In addition, high adoption of enhanced medical devices and availability of well-established medical centers in countries, such as Germany, France, and the U.K. are expected to maintain steady market growth.
Moderate growth of the balloon valvuloplasty devices market is in Latin America due to a growing focus on minimally invasive cardiac procedures and improving healthcare infrastructure. As access to interventional cardiology services expands in countries, there is a slow but increasing adoption of balloon valvuloplasty. Despite the issues, such as restricted reimbursement coverage and economic constraints in the region, continuous funding for public health care and awareness generation is responsible for the balloon valvuloplasty devices market growth.
Moderate growth in the MEA region is supported by high incidences of cardiovascular diseases and growing efforts in the modernization of healthcare systems. Higher-income countries with much higher access to technology (and health-care), such as Saudi Arabia, the UAE, and South Africa, there is more growth concentrated. The growth of the market is still being restrained by slower conditions of advanced medical technology adoption and inequitable access to health services that are still prevailing in many places throughout the region. However, the renewed focus on enhancing cardiac care is anticipated to uphold a steady but gradual growth of the market despite these challenges.
Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronic plc, Meril Life Sciences Pvt. Ltd., B. Braun Melsungen AG, Cordis (a Cardinal Health company), Lepu Medical Technology Co., Ltd., Balton Sp. o.o., JenaValve Technology, Inc., Translumina Therapeutics LLP, and other players.
March 2024 – Boston Scientific Corporation announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its AGENT Drug-Coated Balloon (DCB). The device is cleared for the treatment of coronary in-stent restenosis (ISR) in patients with coronary artery disease. ISR is the re-narrowing or blockage of a stented blood vessel that occurred previously due to plaque accumulation or scarring.
| Report Attributes | Details |
|---|---|
| Market Size in 2024 | USD 2.40 Billion |
| Market Size by 2032 | USD 3.66 Billion |
| CAGR | CAGR of 5.44% From 2025 to 2032 |
| Base Year | 2024 |
| Forecast Period | 2025-2032 |
| Historical Data | 2021-2023 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product Type (Standard Balloon, Cutting Balloon, Scoring Balloon, High-Pressure Balloon, Low-Pressure Balloon) • By Application (Aortic Valve Stenosis, Pulmonary Valve Stenosis) • By Age Group (Pediatric, Adult) • By End-use (Hospitals, Ambulatory Surgical Centres, Specialty Clinics, Other End-users) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronic plc, Meril Life Sciences Pvt. Ltd., B. Braun Melsungen AG, Cordis (a Cardinal Health company), Lepu Medical Technology Co., Ltd., Balton Sp. z o.o., JenaValve Technology, Inc., Translumina Therapeutics LLP, and other players. |
Ans: The Balloon Valvuloplasty Devices Market is expected to grow at a CAGR of 5.44% from 2025 to 2032.
Ans: The Balloon Valvuloplasty Devices Market was USD 2.40 billion in 2024 and is expected to reach USD 3.66 billion by 2032.
Ans: Increased incidence of heart disorders related to valves is driving the market growth.
Ans: The “Aortic valve stenosis” segment dominated the Balloon Valvuloplasty Devices Market.
Ans: North America dominated the Balloon Valvuloplasty Devices Market in 2024.
Table Of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2024)
5.2 Procedure and Prescription Trends (2024), by Region
5.3 Healthcare Spending, by Region (Government, Commercial, Private, Out-of-Pocket), 2024
6. Competitive Landscape
6.1 List of Major Companies By Region
6.2 Market Share Analysis By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Balloon Valvuloplasty Devices Market Segmentation By Product Type
7.1 Chapter Overview
7.2 Standard balloon
7.2.1 Standard balloon Market Trends Analysis (2021-2032)
7.2.2 Standard balloon Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Cutting balloon
7.3.1 Cutting Balloon Market Trends Analysis (2021-2032)
7.3.2 Cutting balloon Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Scoring balloon
7.4.1 Scoring balloon Market Trends Analysis (2021-2032)
7.4.2 Scoring balloon Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 High-pressure balloon
7.5.1 High-pressure balloon Market Trends Analysis (2021-2032)
7.5.2 High-pressure balloon Market Size Estimates and Forecasts to 2032 (USD Billion)
7.6 Low-pressure balloon
7.6.1 Low-pressure balloon Market Trends Analysis (2021-2032)
7.6.2 Low-pressure balloon Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Balloon Valvuloplasty Devices Market Segmentation By Application
8.1 Chapter Overview
8.2 Aortic valve stenosis
8.2.1 Aortic Valve Stenosis Market Trends Analysis (2021-2032)
8.2.2 Aortic valve stenosis Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Pulmonary valve stenosis
8.3.1 Pulmonary valve stenosis Market Trends Analysis (2021-2032)
8.3.2 Pulmonary valve stenosis Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Balloon Valvuloplasty Devices Market Segmentation By Age Group
9.1 Chapter Overview
9.2 Pediatric
9.2.1 Pediatric Market Trends Analysis (2021-2032)
9.2.2 Pediatric Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Adult
9.3.1 Cloud-Based Market Trends Analysis (2021-2032)
9.3.2 Cloud-Based Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Balloon Valvuloplasty Devices Market Segmentation by End-User
10.1 Chapter Overview
10.2 Hospitals
10.2.1 Hospitals Market Trends Analysis (2021-2032)
10.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Billion)
10.3 Ambulatory surgical centres
10.3.1 Ambulatory Surgical Centres Market Trend Analysis (2021-2032)
10.3.2 Ambulatory Surgical Centres Market Size Estimates and Forecasts to 2032 (USD Billion)
10.4 Specialty clinics
10.4.1 Specialty Clinics Market Trends Analysis (2021-2032)
10.4.2 Specialty clinics Market Size Estimates and Forecasts to 2032 (USD Billion)
10.5 Other end-users
10.5.1 Other end-users Market Trends Analysis (2021-2032)
10.5.2 Other end-users Market Size Estimates and Forecasts to 2032 (USD Billion)
11. Regional Analysis
11.1 Chapter Overview
11.2 North America
11.2.1 Trend Analysis
11.2.2 North America Balloon Valvuloplasty Devices Market Estimates and Forecasts by Country (2021-2032) (USD Billion)
11.2.3 North America Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.2.4 North America Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.2.5 North America Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.2.6 North America Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.2.7 USA
11.2.7.1 USA Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.2.7.2 USA Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.2.7.3 USA Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.2.7.4 USA Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.2.8 Canada
11.2.8.1 Canada Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.2.8.2 Canada Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.2.8.3 Canada Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.2.8.4 Canada Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.2.9 Mexico
11.2.9.1 Mexico Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.2.9.2 Mexico Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.2.9.3 Mexico Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.2.9.4 Mexico Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.3 Europe
11.3.1 Trend Analysis
11.3.2 Europe Balloon Valvuloplasty Devices Market Estimates and Forecasts by Country (2021-2032) (USD Billion)
11.3.3 Europe Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.3.4 Europe Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.3.5 Europe Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.3.6 Europe Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.3.7 Germany
11.3.7.1 Germany Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.3.7.2 Germany Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.3.7.3 Germany Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.3.7.4 Germany Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.3.8 France
11.3.8.1 France Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.3.8.2 France Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.3.8.3 France Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.3.8.4 France Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.3.9 UK
11.3.9.1 UK Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.3.9.2 UK Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.3.9.3 UK Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.3.9.4 UK Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.3.10 Italy
11.3.10.1 Italy Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.3.10.2 Italy Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.3.10.3 Italy Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.3.10.4 Italy Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.3.11 Spain
11.3.11.1 Spain Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.3.11.2 Spain Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.3.11.3 Spain Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.3.11.4 Spain Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.3.12 Poland
11.3.12.1 Poland Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.3.12.2 Poland Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.3.12.3 Poland Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.3.12.4 Poland Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.3.13 Turkey
11.3.13.1 Turkey Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.3.13.2 Turkey Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.3.13.3 Turkey Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.3.13.4 Turkey Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.3.14 Rest of Europe
11.3.14.1 Rest of Europe Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.3.14.2 Rest of Europe Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.3.14.3 Rest of Europe Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.3.14.4 Rest of Europe Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.4 Asia Pacific
11.4.1 Trend Analysis
11.4.2 Asia Pacific Balloon Valvuloplasty Devices Market Estimates and Forecasts by Country (2021-2032) (USD Billion)
11.4.3 Asia Pacific Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.4.4 Asia Pacific Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.4.5 Asia Pacific Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.4.6 Asia Pacific Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.4.7 China
11.4.7.1 China Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.4.7.2 China Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.4.7.3 China Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.4.7.4 China Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.4.8 India
11.4.8.1 India Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.4.8.2 India Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.4.8.3 India Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.4.8.4 India Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.4.9 Japan
11.4.9.1 Japan Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.4.9.2 Japan Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.4.9.3 Japan Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.4.9.4 Japan Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.4.10 South Korea
11.4.10.1 South Korea Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.4.10.2 South Korea Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.4.10.3 South Korea Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.4.10.4 South Korea Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.4.11 Singapore
11.4.11.1 Singapore Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.4.11.2 Singapore Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.4.11.3 Singapore Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.4.11.4 Singapore Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.4.12 Australia
11.4.12.1 Australia Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.4.12.2 Australia Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.4.12.3 Australia Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.4.12.4 Australia Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.4.13 Rest of Asia Pacific
11.4.13.1 Rest of Asia Pacific Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.4.13.2 Rest of Asia Pacific Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.4.13.3 Rest of Asia Pacific Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.4.13.4 Rest of Asia Pacific Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.5 Middle East and Africa
11.5.1 Trend Analysis
11.5.2 Middle East and Africa Balloon Valvuloplasty Devices Market Estimates and Forecasts by Country (2021-2032) (USD Billion)
11.5.3 Middle East and Africa Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.5.4 Middle East and Africa Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.5.5 Middle East and Africa Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.5.6 Middle East and Africa Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.5.7 UAE
11.5.7.1 UAE Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.5.7.2 UAE Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.5.7.3 UAE Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.5.7.4 UAE Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.5.8 Saudi Arabia
11.5.8.1 Saudi Arabia Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.5.8.2 Saudi Arabia Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.5.8.3 Saudi Arabia Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.5.8.4 Saudi Arabia Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.5.9 Qatar
11.5.9.1 Qatar Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.5.9.2 Qatar Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.5.9.3 Qatar Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.5.1.9.4 Qatar Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.5.10 South Africa
11.5.10.1 South Africa Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.5.10.2 South Africa Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.5.10.3 South Africa Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.5.10.4 South Africa Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.5.11 Rest of Middle East & Africa
11.5.11.1 Rest of Middle East & Africa Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.5.11.2 Rest of Middle East & Africa Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.5.11.3 Rest of Middle East & Africa Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.5.11.4 Rest of Middle East & Africa Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.6 Latin America
11.6.1 Trend Analysis
11.6.2 Latin America Balloon Valvuloplasty Devices Market Estimates and Forecasts by Country (2021-2032) (USD Billion)
11.6.3 Latin America Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.6.4 Latin America Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.6.5 Latin America Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.6.6 Latin America Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.6.7 Brazil
11.6.7.1 Brazil Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.6.7.2 Brazil Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.6.7.3 Brazil Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.6.7.4 Brazil Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.6.8 Argentina
11.6.8.1 Argentina Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.6.8.2 Argentina Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.6.8.3 Argentina Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.6.8.4 Argentina Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
11.6.9 Rest of Latin America
11.6.9.1 Rest of Latin America Balloon Valvuloplasty Devices Market Estimates and Forecasts By Product Type (2021-2032) (USD Billion)
11.6.9.2 Rest of Latin America Balloon Valvuloplasty Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
11.6.9.3 Rest of Latin America Balloon Valvuloplasty Devices Market Estimates and Forecasts By Age Group (2021-2032) (USD Billion)
11.6.9.4 Rest of Latin America Balloon Valvuloplasty Devices Market Estimates and Forecasts by End-User (2021-2032) (USD Billion)
12. Company Profiles
12.1 Boston Scientific Corporation
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Products/ Services Offered
12.1.4 SWOT Analysis
12.2 Edwards Lifesciences Corporation
12.2.1 Company Overview
12.2.2 Financial
12.2.3 Products/ Services Offered
12.2.4 SWOT Analysis
12.3 Medtronic plc
12.3.1 Company Overview
12.3.2 Financial
12.3.3 Products/ Services Offered
12.3.4 SWOT Analysis
12.4 Meril Life Sciences Pvt. Ltd.
12.4.1 Company Overview
12.4.2 Financial
12.4.3 Products/ Services Offered
12.4.4 SWOT Analysis
12.5 B. Braun Melsungen AG,
12.5.1 Company Overview
12.5.2 Financial
12.5.3 Products/ Services Offered
12.5.4 SWOT Analysis
12.6 Cordis (a Cardinal Health company),
12.6.1 Company Overview
12.6.2 Financial
12.6.3 Products/ Services Offered
12.6.4 SWOT Analysis
12.7 Lepu Medical Technology Co., Ltd.
12.7.1 Company Overview
12.7.2 Financial
12.7.3 Products/ Services Offered
12.7.4 SWOT Analysis
12.8 Balton Sp. z o.o.,
12.8.1 Company Overview
12.8.2 Financial
12.8.3 Products/ Services Offered
12.8.4 SWOT Analysis
12.9 Translumina Therapeutics LLP,
12.9.1 Company Overview
12.9.2 Financial
12.9.3 Products/ Services Offered
12.9.4 SWOT Analysis
12.10 JenaValve Technology Inc.
12.10.1 Company Overview
12.10.2 Financial
12.10.3 Products/ Services Offered
12.10.4 SWOT Analysis
13. Use Cases and Best Practices
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments:
By Product Type
Standard balloon
Cutting balloon
Scoring balloon
High-pressure balloon
Low-pressure balloon
By Application
Aortic valve stenosis
Pulmonary valve stenosis
By Age Group
Pediatric
Adult
By End-Use
Hospitals
Ambulatory surgical centres
Specialty clinics
Other end-users
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Poland
Turkey
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
UAE
Saudi Arabia
Qatar
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players